Lenovo ranks Eighth in the Gartner® Supply Chain Top 25 for 2023
RALEIGH, N.C.–(BUSINESS WIRE)–Lenovo has once again been named in the Gartner Supply Chain Top 25…
RALEIGH, N.C.–(BUSINESS WIRE)–Lenovo has once again been named in the Gartner Supply Chain Top 25…
Next-level VR headset in a compact form factor with mixed reality capabilities for immersive training,…
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or…
A type of artificial intelligence (AI), Deep Learning (DL) technology can advance medical imaging capabilities…
Vancouver, British Columbia–(Newsfile Corp. – May 30, 2023) – Kovo HealthTech Corporation (TSXV: KOVO) (the…
Luxembourg, May 31, 2023 – (ACN Newswire) – Moolec Science SA (NASDAQ: MLEC) a science-based…
TORONTO–(BUSINESS WIRE)–Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol” or the “Company”), a leader in smart…
Accelerating workload migrations to the cloud for shared customers, with expanded collaboration and new AWS…
Mobilitie was selected by joint venture partners, AEG & Southwest Value Partners, to deliver a…
Lens Control Center simplifies secure Kubernetes deployments CAMPBELL, Calif.–(BUSINESS WIRE)–#Lens—Mirantis, freeing developers to create their…
UTRECHT, The Netherlands and PHILADELPHIA, May 30, 2023 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
UTRECHT, The Netherlands and PHILADELPHIA, May 30, 2023 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology…
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology…
DURHAM, N.C. and EXTON, Pa., May 30, 2023 (GLOBE NEWSWIRE) — Aceragen, Inc. (the “Company”)…
DURHAM, N.C. and EXTON, Pa., May 30, 2023 (GLOBE NEWSWIRE) — Aceragen, Inc. (the “Company”)…
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology…
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology…